Flexible dosed duloxetine versus placebo in the treatment of fibromyalgia.

Trial Profile

Flexible dosed duloxetine versus placebo in the treatment of fibromyalgia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2011

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Fibromyalgia; Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 08 May 2010 Results were presented at the 29th Annual Scientific Meeting of the American Pain Society.
    • 19 Aug 2009 Actual patient number (513) added as reported by ClinicalTrials.gov.
    • 19 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top